Clinical trial
Exploratory Study on LNP-mRNA Drugs Targeting CD19/BCMA for the Treatment of Relapsed and Refractory Autoimmune Diseases
NCT07388212 is registered in ClinicalTrials.gov with West China Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Exploratory Study on LNP-mRNA Drugs Targeting CD19/BCMA for the Treatment of Relapsed and Refractory Autoimmune Diseases
- Lead sponsor
- West China Hospital
- Phase
- Phase 1
- Overall status
- Not yet recruiting
- Start date
- February 23, 2026
- Completion date
- December 31, 2028
- Enrollment
- 27 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.